NEWS

WIRES

OTHER

Concorde Subsidiary Appoints Medical Advisor to Its BEVCORP Management Team

Concorde Resources Corp. (OTC: CCDE), is pleased to announce that its majority-owned subsidiary, BEVCORP International, Inc., d/b/a Beverly Hills Weight Loss & Wellness®, has appointed Dr. Peter Holyk to its Medical Advisory team.

Dr. Peter R. Holyk graduated from Tufts University School of Medicine in Boston, MA in 1978 and received a Bachelor of Science degree in Chemistry, Magna Cum Laude with High Honors from Seton Hall University in 1974. He conducted a General Medical Internship at Moses H. Cone Memorial Hospital in Greensboro, NC from 1978-1979.

His Licensure and Certifications include: North Carolina State Physician's License, Florida State Physician's License, South Carolina State Physician's License, Certified, American Board of Ophthalmology and Certified Nutrition Specialist (CNS).

Other medical accomplishments include: American College of Surgeons, Fellow; American Academy of Ophthalmology, Fellow; American Board of Chelation Therapists "Diplomate Candidate;" Nambudripad's Allergy Elimination Therapy; Mercury Detoxification Investigational Review Board of GLACM/FDA; American Board of Neural Therapy, and Human Growth Hormone Investigational Review Board GLACM/FDA.

Past and present professional memberships include: American College for the Advancement of Medicine, Florida Medical Association, American Academy of Ophthalmology, Indian River County Medical Society, Contact Lens Association of Ophthalmologists, Southern Medical Association, Fellow, American College of Surgeons, American College For The Advancement of Medicine, International College of Integrative, International Oxidative Medicine Association, and International College of Advanced Longevity Medicine.

In addition to authoring several articles and book chapters, Dr. Holyk has lectured extensively and written numerous newspaper columns. Current ventures include both radio and television appearances on local and national shows and an Internet column. Dr. Holyk currently practices natural hormone replacement therapy, nutrition and supplementation counseling, wellness, and disease prevention. He founded Contemporary Health Innovations to help bridge the gap between traditional and "alternative" medicines for the ultimate betterment of the patient

"Dr. Holyk brings to BEVCORP International a wealth of knowledge, and will serve as an invaluable asset during the research, and development of new products. Through careful testing and proper research, Dr. Holyk will be able to help us in determining which new products can provide the best results to our target market, and add the greatest value to our company as a whole," said Kenneth Macdonald, Director of CCDE.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made on behalf of the company. All such forward-looking statements are, by necessity, only estimates of future results and actual results achieved by CCDE may differ materially from these statements due to a number of factors. CCDE assumes no obligations to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such statements. You should independently investigate and fully understand all risks before making investment decisions.

Distributed by Market Wire